These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
246 related articles for article (PubMed ID: 34658870)
1. The Future of Gene Therapy for Transfusion-Dependent Beta-Thalassemia: The Power of the Lentiviral Vector for Genetically Modified Hematopoietic Stem Cells. Rattananon P; Anurathapan U; Bhukhai K; Hongeng S Front Pharmacol; 2021; 12():730873. PubMed ID: 34658870 [TBL] [Abstract][Full Text] [Related]
2. Hemoglobin disorders: lentiviral gene therapy in the starting blocks to enter clinical practice. Sii-Felice K; Giorgi M; Leboulch P; Payen E Exp Hematol; 2018 Aug; 64():12-32. PubMed ID: 29807062 [TBL] [Abstract][Full Text] [Related]
4. New therapeutic targets in transfusion-dependent and -independent thalassemia. Cappellini MD; Motta I Hematology Am Soc Hematol Educ Program; 2017 Dec; 2017(1):278-283. PubMed ID: 29222267 [TBL] [Abstract][Full Text] [Related]
5. Bone marrow as a source of hematopoietic stem cells for human gene therapy of β-thalassemia. Frittoli MC; Biral E; Cappelli B; Zambelli M; Roncarolo MG; Ferrari G; Ciceri F; Marktel S Hum Gene Ther; 2011 Apr; 22(4):507-13. PubMed ID: 20979441 [TBL] [Abstract][Full Text] [Related]
6. Gene Therapy in Patients with Transfusion-Dependent β-Thalassemia. Thompson AA; Walters MC; Kwiatkowski J; Rasko JEJ; Ribeil JA; Hongeng S; Magrin E; Schiller GJ; Payen E; Semeraro M; Moshous D; Lefrere F; Puy H; Bourget P; Magnani A; Caccavelli L; Diana JS; Suarez F; Monpoux F; Brousse V; Poirot C; Brouzes C; Meritet JF; Pondarré C; Beuzard Y; Chrétien S; Lefebvre T; Teachey DT; Anurathapan U; Ho PJ; von Kalle C; Kletzel M; Vichinsky E; Soni S; Veres G; Negre O; Ross RW; Davidson D; Petrusich A; Sandler L; Asmal M; Hermine O; De Montalembert M; Hacein-Bey-Abina S; Blanche S; Leboulch P; Cavazzana M N Engl J Med; 2018 Apr; 378(16):1479-1493. PubMed ID: 29669226 [TBL] [Abstract][Full Text] [Related]
7. Amelioration of murine beta-thalassemia through drug selection of hematopoietic stem cells transduced with a lentiviral vector encoding both gamma-globin and the MGMT drug-resistance gene. Zhao H; Pestina TI; Nasimuzzaman M; Mehta P; Hargrove PW; Persons DA Blood; 2009 Jun; 113(23):5747-56. PubMed ID: 19365082 [TBL] [Abstract][Full Text] [Related]
8. A novel murine model of Cooley anemia and its rescue by lentiviral-mediated human beta-globin gene transfer. Rivella S; May C; Chadburn A; Rivière I; Sadelain M Blood; 2003 Apr; 101(8):2932-9. PubMed ID: 12480689 [TBL] [Abstract][Full Text] [Related]
9. Permanent and panerythroid correction of murine beta thalassemia by multiple lentiviral integration in hematopoietic stem cells. Imren S; Payen E; Westerman KA; Pawliuk R; Fabry ME; Eaves CJ; Cavilla B; Wadsworth LD; Beuzard Y; Bouhassira EE; Russell R; London IM; Nagel RL; Leboulch P; Humphries RK Proc Natl Acad Sci U S A; 2002 Oct; 99(22):14380-5. PubMed ID: 12391330 [TBL] [Abstract][Full Text] [Related]
10. Hurdles to the Adoption of Gene Therapy as a Curative Option for Transfusion-Dependent Thalassemia. Thuret I; Ruggeri A; Angelucci E; Chabannon C Stem Cells Transl Med; 2022 Apr; 11(4):407-414. PubMed ID: 35267028 [TBL] [Abstract][Full Text] [Related]
11. Successful correction of the human Cooley's anemia beta-thalassemia major phenotype using a lentiviral vector flanked by the chicken hypersensitive site 4 chromatin insulator. Malik P; Arumugam PI; Yee JK; Puthenveetil G Ann N Y Acad Sci; 2005; 1054():238-49. PubMed ID: 16339671 [TBL] [Abstract][Full Text] [Related]
12. Parallel assessment of globin lentiviral transfer in induced pluripotent stem cells and adult hematopoietic stem cells derived from the same transplanted β-thalassemia patient. Tubsuwan A; Abed S; Deichmann A; Kardel MD; Bartholomä C; Cheung A; Negre O; Kadri Z; Fucharoen S; von Kalle C; Payen E; Chrétien S; Schmidt M; Eaves CJ; Leboulch P; Maouche-Chrétien L Stem Cells; 2013 Sep; 31(9):1785-94. PubMed ID: 23712774 [TBL] [Abstract][Full Text] [Related]
13. Hematopoietic stem cell gene transfer for the treatment of hemoglobin disorders. Persons DA Hematology Am Soc Hematol Educ Program; 2009; ():690-7. PubMed ID: 20008255 [TBL] [Abstract][Full Text] [Related]
14. Genetic therapy for beta-thalassemia: from the bench to the bedside. Arumugam P; Malik P Hematology Am Soc Hematol Educ Program; 2010; 2010():445-50. PubMed ID: 21239833 [TBL] [Abstract][Full Text] [Related]